Mild to Moderate Asthma
Respiratory·MeSH: Asthma
Prevalence
8000.0 / 100K
Incidence
400.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| CDX-622 | Celldex Therapeutics, Inc. (CLDX) |
Frequently asked questions
How many drugs are in development for Mild to Moderate Asthma?
BioSniper tracks 1 drug in development for Mild to Moderate Asthma across 1 company.
How many clinical trials target Mild to Moderate Asthma?
There are 1 clinical trial targeting Mild to Moderate Asthma tracked by BioSniper.
What is the prevalence of Mild to Moderate Asthma?
The estimated prevalence of Mild to Moderate Asthma is approximately 8000.0 per 100,000 population.
Deep-dive into Mild to Moderate Asthma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis